NCT02041663View on ClinicalTrials.gov

Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

March 5, 2012

Primary Completion Date

July 11, 2018

Study Completion Date

July 11, 2018

Conditions
Meningococcal InfectionsSeptic ShockSevere Sepsis
Interventions
BIOLOGICAL

BNP

Repeated brain natriuretic peptide dosages and cardiac echographies up to day 5

Trial Locations (1)

75015

AP-HP, Necker hospital, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02041663 - Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis | Biotech Hunter | Biotech Hunter